Micropulse laser for diabetic macular edema
Part of Eyes & vision, Hormones & metabolism clinical trials.
This trial tests a special laser treatment for diabetic macular edema, a swelling in the back of the eye caused by diabetes. It aims to see if the laser can help patients who have not improved with standard treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have type 1 or type 2 diabetes.
- Your vision in the study eye is 20/400 or better (able to read the largest letter on an eye chart).
- You have a specific type of macular swelling (center-involved diabetic macular edema).
- Your eye has no active bleeding or severe eye conditions that could interfere with the laser or measurements.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a medication called dapagliflozin, which is usually used for diabetes and heart failure, can help reduce swelling in the retina (diabetic macular edema) and improve vision. It is for people with type 2 diabetes who are already taking insulin and metformin.
This trial tests a gentle laser treatment (micropulse laser) to reduce swelling in the center of the retina caused by diabetes. The goal is to improve or protect your vision without the need for injections or stronger laser.
This study tests whether a micropulsed laser can reduce swelling in the macula (central vision area) in people with inherited retinal diseases. It may help improve or stabilize vision-related swelling seen on detailed eye scans.
This trial tests whether switching from anti-VEGF injections to a special laser is better than continuing injections alone for people with diabetic macular edema whose central retinal thickness has dropped below 400 microns after the first year of treatment.
This study tests whether using a special eye scan (OCTA) to guide targeted laser treatment can slow down the progression of areas with poor blood flow in the retina of people with diabetic retinopathy. The goal is to prevent the condition from getting worse and help preserve your vision.
This study tests a gentle laser treatment called micropulse laser for people with chronic central serous chorioretinopathy. It aims to help dry up the fluid under the retina that has not responded to standard medications for at least 6 months.
Hear when a new Treatment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.